Aflatoxin P-1: a new aflatoxin metabolite in monkeys

Area of Science:

• Toxicology
• Metabolomics
• Analytical Chemistry

Background:

• Aflatoxin B(1) is a toxic fungal metabolite with carcinogenic properties.
• Understanding aflatoxin B(1) metabolism is crucial for assessing human health risks.
• Urinary metabolites serve as biomarkers for exposure assessment.

Purpose of the Study:

• To identify and characterize the primary urinary metabolite of aflatoxin B(1) in a non-human primate model.
• To explore the potential of this metabolite as a biomarker for human aflatoxin B(1) exposure.

Main Methods:

• Rhesus monkeys were administered aflatoxin B(1).
• Urine samples were collected and analyzed using advanced analytical techniques (e.g., mass spectrometry).
• The structure of the principal metabolite was elucidated.

Main Results:

• A novel phenolic derivative of aflatoxin B(1) was identified as the major urinary metabolite.
• This metabolite was predominantly found in a conjugated form.
• The findings establish a key metabolic pathway for aflatoxin B(1) in primates.

Conclusions:

• The identified phenolic derivative is the principal urinary metabolite of aflatoxin B(1) in rhesus monkeys.
• Detection of this metabolite in human urine could provide a valuable tool for estimating aflatoxin exposure.
• This research contributes to the development of improved methods for monitoring mycotoxin contamination and its health impacts.